Scor

The worst is behind

09/09/20 -"Scor has adjusted its strategic targets for 2020, taking into consideration the COVID-19 pansemic. The good news was the lower than booked emerging Life claims in the US (€182m booked in the H1 20 ..."

PDF page sample
Pages
57
Language
English
Published on
09/09/20
Download
You may also be interested by these reports :
29/12/25
We have revised our forecasts following Aegon’s December 2025 CMD, at which the group confirmed its relocation plans to the US, and announced its ...
29/12/25
At its December 2025 CMD, Aegon confirmed its plans to relocate to the US and announced slightly disappointing targets for the FY25–27 period. In ...
18/12/25
Storebrand has presented a convincing strategic plan at its CMD. While the group’s growth drivers are expected to remain broadly unchanged, we were ...
17/12/25
Uniqa’s recent CME conveyed a strong sense of optimism, and rightly so in our view. Beyond the formal upgrade of the FY28 targets, the key takeaways ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO